Lipocalin-2 as a mediator of neuroimmune communication
Journal of Leukocyte Biology · 25.07.2024 · 116 (2) · 357-368
DOI: 10.1093/jleuko/qiad157 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Leukocyte Biology, online erschienen am 27.12.2023. Verfasst von Ruqayya Afridi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, School of Medicine, Kyungpook National University, 680 Gukchaebosang Street, Joong-gu, Daegu 41944, Republic of Korea. Hauptthemen laut MEDLINE: Lipocalin-2, Neuroimmunomodulation. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 127 Literaturangaben.
Abstract (Originalsprache)
Lipocalin-2, a neutrophil gelatinase-associated lipocalin, is a 25-kDa secreted protein implicated in a broad range of inflammatory diseases affecting the brain and periphery. It is a pleotropic protein expressed by various immune and nonimmune cells throughout the body. Importantly, the surge in lipocalin-2 levels in disease states has been associated with a myriad of undesirable effects, further exacerbating the ongoing pathological processes. In the brain, glial cells are the principal source of lipocalin-2, which plays a definitive role in determining their functional phenotypes. In different central nervous system pathologies, an increased expression of glial lipocalin-2 has been linked to neurotoxicity. Lipocalin-2 mediates a crosstalk between central and peripheral immune cells under neuroinflammatory conditions. One intriguing aspect is that elevated lipocalin-2 levels in peripheral disorders, such as cancer, metabolic conditions, and liver diseases, potentially incite an inflammatory activation of glial cells while disrupting neuronal functions. This review comprehensively summarizes the influence of lipocalin-2 on the exacerbation of neuroinflammation by regulating various cellular processes. Additionally, this review explores lipocalin-2 as a mediator of neuroimmune crosstalk in various central nervous system pathologies and highlights the role of lipocalin-2 in carrying inflammatory signals along the neuroimmune axis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, School of Medicine, Kyungpook National University, 680 Gukchaebosang Street, Joong-gu, Daegu 41944, Republic of Korea.
- Brain Korea 21 four KNU Convergence Educational Program of Biomedical Sciences for Creative Future Talents, Kyungpook National University, 680 Gukchaebosang Street, Joong-gu, Daegu 41940, Republic of Korea.
- School of Life Sciences, BK21 plus KNU Creative BioResearch Group, Kyungpook National University, 80 Daehak-ro, Buk-gu, Daegu 41566, Republic of Korea.
- Brain Science and Engineering Institute, Kyungpook National University, 680 Gukchaebosang Street, Joong-gu, Daegu 41944, Republic of Korea.
ORCID-Profile: Kyoungho Suk
Zitieren
APA
Afridi, R., Kim, J. H., Bhusal, A., Lee, W. H., & Suk, K. (2024). Lipocalin-2 as a mediator of neuroimmune communication. Journal of Leukocyte Biology, 116(2), 357-368. https://doi.org/10.1093/jleuko/qiad157
Vancouver
Afridi R, Kim JH, Bhusal A, Lee WH, Suk K. Lipocalin-2 as a mediator of neuroimmune communication. Journal of Leukocyte Biology. 2024;116(2):357-368. doi:10.1093/jleuko/qiad157
BibTeX
@article{Afridi2024,
author = {Afridi, Ruqayya and Kim, Jae-Hong and Bhusal, Anup and Lee, Won-Ha and Suk, Kyoungho},
title = {Lipocalin-2 as a mediator of neuroimmune communication},
journal = {Journal of Leukocyte Biology},
year = {2024},
volume = {116},
number = {2},
pages = {357--368},
doi = {10.1093/jleuko/qiad157}
}
EUVIMED